CINA-PE
Avicenna.AI
Information source:
Vendor
Last updated: July 9, 2024 |
General Information
General | |
---|---|
Product name | CINA-PE |
Company | Avicenna.AI |
Subspeciality | Chest |
Modality | CT |
Disease targeted | Pulmonary embolism |
Key-features | Pulmonary embolism detection, pulmonary embolism triage |
Suggested use | Before: adapting worklist order |
Technical Specifications
Data characteristics | |
---|---|
Population | Adults suspected of pulmonary embolism |
Input | Chest and thoraco-abdominal CT angiographies (CTA) |
Input format | DICOM |
Output | bounding box annotation, notification |
Output format | DICOM SC, GSPS |
Technology | |
Integration | Integration via AI marketplace or distribution platform, Stand-alone third party application |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker) |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | 10 - 60 seconds |
Regulatory
Certification | |
---|---|
CE |
Certified,
Class IIb
, MDR
|
FDA | 510(k) cleared , Class II |
Intended Use Statements | |
Intended use (according to CE) | CINA CHEST is a radiological computer aided triage and notification software indicated for use in the analysis of Chest and Thoraco-abdominal CT angiography. The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and communicating suspected positive findings of (1) Chest CT angiography for Pulmonary Embolism (PE) and (2) Chest or Thoraco-abdominal CT angiography for Aortic Dissection (AD). CINA CHEST uses an artificial intelligence algorithm to analyze images and highlight cases with detected PE and AD on a standalone Web application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected PE or AD findings. Notifications include compressed preview images that are meant for informational purposes only, and are not intended for diagnostic use beyond notification. The device does not alter the original medical image, and it is not intended to be used as a diagnostic device. The results of CINA CHEST are intended to be used in conjunction with other patient information and based on professional judgment to assist with triage/prioritization of medical images. Notified clinicians are ultimately responsible for reviewing full images per the standard of care. |
Market
Market presence | |
---|---|
On market since | 12-2020 |
Distribution channels | Viz.ai Platform, CARPL.ai, Eureka Clinical AI |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | |
Based on |
Evidence
Evidence | |
---|---|
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |